mounjaro tirzepatide news today september 2025 and Wegovy: Price Changes Coming Mounjaro approved for use in
Description
Common side effects include mild nausea and appetite reduction, which typically subside within weeks
FDA-approved in March, the new dose showed average weight loss of approximately 21% at 72 weeks in the phase 3 STEP UP trial
MN: Just like any other medication, GLP-1s may not work the same way for everyone
Even when a medication is technically on formulary, the prior authorization process can delay treatment by weeks or result in denial if documentation is incomplete
While this slowdown in bowel movements typically improves within 48 weeks as your body adapts, understanding safe management strategiesincluding appropriate laxative usehelps you stay comfortable during your weight loss journey
RahimiHRMohammadpourAHDastaniMJaafariMRAbnousKGhayour MobarhanMet al
